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ABSTRACT
The genome stability is maintained by coordinated
action of DNA repairs and checkpoints, which delay
progression through the cell cycle in response to
DNA damage. Rad9 is conserved from yeast to
human and functions in cell cycle checkpoint
controls. Here, a regulatory mechanism for Rad9
function is reported. In this study Rad9 has been
found to interact with and be methylated by
protein arginine methyltransferase 5 (PRMT5).
Arginine methylation of Rad9 plays a critical role in
S/M and G2/M cell cycle checkpoints. The activation
of the Rad9 downstream checkpoint effector Chk1
is impaired in cells only expressing a mutant Rad9
that cannot be methylated. Additionally, Rad9
methylation is also required for cellular resistance
to DNA damaging stresses. In summary, we un-
covered that arginine methylation is important for
regulation of Rad9 function, and thus is a major
element for maintaining genome integrity.
INTRODUCTION
DNA repair and cell cycle checkpoint cooperate in
minimizing the DNA damage constantly caused by intra-
cellular and environmental genotoxic stresses and main-
taining genomic integrity. Mutation in genes functioning
in these two systems often leads to ‘mutator’ phenotype
and enhances susceptibility to tumor development (1).
Rad9 is conserved from yeast to human, and is critical
for both DNA repair and cell cycle checkpoint control
(2,3). Rad9 is required for homologous recombination,
base excision and mismatch repairs (4–6), and for G2/M
and S/M checkpoint activation (7,8).
Protein arginine methylation is a post-translational modi-
ﬁcation that results in symmetrical or asymmetrical
dimethylarginines (9). Protein arginine methyltransferases
(PRMTs) are classiﬁed as types I, II, III or IV enzymes.
Types I, II and III PRMTs methylate terminal (or o)
guanidino nitrogen atoms. Both type I and type II
enzymes catalyze the formation of a mono-methylated
(MMA) intermediate, subsequently type I PRMTs
( P R M T 1 ,3 ,4 ,6a n d8 )f u r t h e rcatalyze the generation of
asymmetrical double-methylated arginine (aDMA), whereas
type II PRMTs (PRMT5, PRMT7 and FBXO11) catalyze
the formation of symmetrical double-methylated arginine
(sDMA) (10). Both type I and II enzymes regulate gene
transcription via methylatingh i s t o n e s ,a n do ther cellular
activities through methylating non-histone proteins.
Several proteins involved in DNA repair (MRE11, p53,
DNA polymerase b) have been shown to be regulated by
arginine methylation (11). In this study, we identiﬁed a
few Rad9-associated proteins by combining immunopre-
cipitation and mass spectroscopy, one of these proteins
was PRMT5 (12–14). It is of interest that both human
and mouse Rad9 contains a methylation consensus
amino acid sequence RGRR. We found that Rad9 form
a complex with PRMT5, and PRMT5 can methylate Rad9
at the RGRR sequence. The methylation is critical for
cellular resistance to hydroxyurea, and for S/M and G2/
M checkpoint activation.
MATERIALS AND METHODS
Mass spectrometry
HEK 293T cells stably expressing FL-hRad9 at a level
close to the endogenous hRad9 expression level were
used for afﬁnity-immunoprecipitation of hRad9-
interacting proteins. The procedure for identifying these
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ously (13).
Antibodies, immunoprecipitation and western blotting
Anti-hRad9 polyclonal antibody was obtained by
immunizing mice with puriﬁed MBP-hRad9 protein and
anti-hRad9 monoclonal antibody (611324) was purchased
from BD. Anti-PRMT5 rabbit polyclonal antibody
(07-405) was from Millipore, and ab412 (anti-mono/
dimethylarginine antibody) was from Abcam. Anti-
FLAG M2 monoclonal antibody (F1804), anti-FLAG
polyclonal antibody (F7425) and FLAG peptide were
obtained from Sigma-Aldrich, and anti-HA antibody
was obtained from Santa Cruz Technology. Phospho-
Chk1 (P-Ser-345) and Chk1 (G-4) antibodies were
purchased from Cell Signaling Technology and Santa
Cruz Biotechnology, respectively. Immunoprecipitation
and western blotting were performed as described previ-
ously (15).
Gene subcloning
pFLAG-CMV2-hRad9, pFLAG-CMV2-hRad1, pET32
(+)-hRad9 and pcDNA3-6HA-hRad9 plasmids have been
described previously (16). Full-length human PRMT5
sequence was ampliﬁed by PCR using cDNA from HEK
293T cells and cloned into pFLAG-CMV2 and
pcDNA3-6HA, respectively. pGEX-6P-1-PRMT5 was
constructed by excising from pFLAG-CMV2-PRMT5
and ligating into the EcoRI site of pGEX-6P-1. PCR
site-directed mutagenesis was performed using the
Quick-Change method (Stratagene). pFLAG-CMV2-
hRad9-3RK was constructed by overlap PCR using
pFLAG-CMV2-hRad9. All constructs generated using
PCR were conﬁrmed by sequencing. The primers and re-
striction sites used are shown in Supplementary Table S1.
RNA interference
To generate the PRMT5 ShRNA vector, oligonucleotides
(50-GATCCCCGGCCATCTATAAATGTCTGTTCAAG
AGACAGACATTTATAGATGGCCTTTTTA-30 and
30GGGCCGGTAGATATTTACAGACAAGTTCTCTGT
CTGTAAATATCTACCGGAAAAATTCGA-50) were
designed to target PRMT5 nucleotides 1016–1034
(shown in boldface). Oligonucleotides were annealed and
cloned into the Bgl II and Hind III sites of the
pSUPERpuro vector. HCT116 cells were transfected
with the pSUPERpuro PRMT5 vector or an empty
pSUPERpuro vector. Cells were treated with 1mg/ml
puromycin for 3 days to eliminate cells without ShRNA.
Cell culture
Mouse ES cells, HeLa cells, HCT16 and HEK 293T cells
were cultured according to previously published methods
(7,13).
Expression of wild-type and mutant hRad9 in mRad9
 / 
ES cells
For R to A mutation analysis, ES cells were trans-
fected using Lipofectamine with pZeoSV2-hRad9 or
pZeoSV2-hRad9-3RA according to the manufacturer’s in-
structions (Invitrogen). Stable clones were selected in
medium containing zeocin at a concentration of 100mg/
ml. Selected transfectants were subsequently cultured at
25mg/ml zeocin to maintain the transfected genes within
the cells. Multiple clones of each mutant expressing similar
levels of protein were used for functional studies. For R to
K mutation analysis, ES cells were transfected using
Lipofectamine with pcDNA3.1-hygromycin (1mg) and
pFLAG-CVM2-hRad9-3RK (3mg) or pFLAG-CVM2-
hRad9 according to the manufacturer’s instructions
(Invitrogen). Stable clones were selected in medium con-
taining hygromycin at a concentration of 150mg/ml.
Selected cells were subsequently cultured at 50mg/ml
hygromycin to maintain the transfected genes within the
cells. Multiple clones of each mutant expressing protein
levels similar to the endogenous protein were used for
functional studies.
GST pull-down
GST fusion proteins were expressed in cells of the
Escherichia coli strain Rosetta (Invitrogen) using
pGEX-6P-1 (GE Health). Puriﬁcation of GST fusion
proteins and in vitro GST pull-down test has been
described previously (13).
ES cell survival and cell cycle checkpoint assays
Mouse ES cells were seeded in duplicate at designated
numbers onto 60-mm gelatinized tissue culture dishes.
Sensitivity to various doses of hydroxyurea (HU), and
60Co g rays was tested using a previously published pro-
cedure (7). Assays for detecting G2/M checkpoint control
and S/M checkpoint function of mouse ES cells were
performed as described previously (7,13).
In vitro methyltransferase assays
HEK 293T cells were transfected with the plasmid
pFLAG-CMV2-PRMT5, and FL-PRMT5 protein was
immunoprecipitated with anti-FLAG agarose beads 24h
after transfection. Puriﬁed GST-hRad9 or GST-hRad9-
3RA (2mg) were incubated with immunoprecipitated
FL-PRMT5 in the presence of 0.55mCi of [methyl-
3H]
AdoMet (Amersham Biosciences) in 25mM Tris–HCl at
pH 7.5 in a ﬁnal volume of 30ml for 60min at 37 C,
histones (sigma) were introduced as a positive control.
Reactions were stopped by adding 6mlo f5   SDS–
PAGE sample buffer, followed by heating at 100 C for
5min. The samples were separated on 10% SDS–PAGE
and stained with Coomassie blue. Destained gels were
dried and exposed to X-ray ﬁlm at  70 C for 14 days.
RESULTS
hRad9 associates with PRMT5 in cells
In the previous studies, using a strategy of immunoafﬁnity-
Mass spectrometry, we found that hRad9 interacts with
several proteins in HEK 293T cells, in which mis-
match repair protein MLH1 was conﬁrmed to be
associated physically and functionally with hRad9 (13).
4720 Nucleic Acids Research, 2011,Vol.39, No. 11The analysis of Mass spectrometry shows that PRMT5, a
key member of PRMTs (12–14), is also among the proteins
associated with FL-hRad9 but not in the proteins
associated with negative control FL-GFP (Figure 1A and
Supplementary Table S2). Interestingly, hRad9 contains
the glycine-arginine rich sequence (GAR) RGRR that
exists in other proteins which have been shown in
previous studies to be methylated by PRMTs (17).
Therefore we chose to further characterize the interaction
of hRad9 with PRMT5.
We used co-immunoprecipitation to conﬁrm the inter-
action between hRad9 and PRMT5. The assay showed
that overexpressed HA-tagged hRad9 (HA-hRad9) inter-
acted with FLAG-tagged PRMT5 (FL-PRMT5) in HEK
293T cells, and did not interact with the negative control
FL-GFP (Figure 1B). Importantly, endogenous PRMT5
and hRad9 were immunoprecipitated from HeLa cell
extract by an anti-hRad9 polyclonal or anti-PRMT5
antibody, but not by pre-immune serum (Figure 1C D).
The data above indicate that hRad9 associates with
PRMT5 in cells.
hRad9 is arginine-methylated by PRMT5
The above data have established that hRad9 interacts with
PRMT5. Interestingly the hRad9 protein harbors a
sequence RGRR (Figure 2A), the typical methylation
target for PRMTs (18–21). The RGRR sequence is
conserved among humans, monkeys, mice and rats, but
only GRR is conserved in horses, calves and dogs, and
the sequence is not conserved in frogs and other lower
animals. Here we examined whether hRad9 is arginine-
methylated. A pcDNA3-6HA plasmid harboring wild-
type hRad9 or mutated hRad9 in which Arg-172,174,175
were all mutated to Ala (hRad9-3RA) was transfected into
HEK 293T cells. The transfected cell lysates were
immunoprecipitated with anti-mono/dimethylarginine
antibodies (ab412), the immunoprecipitated proteins
were fractionated by SDS-PAGE and monitored with
anti-HA antibody. As shown in Figure 2B, HA-hRad9
was clearly detected in proteins immunoprecipitated by
ab412, while HA-hRad9-3RA could not be detected.
These results indicate that hRad9 is methylated in vivo.
Having shown that hRad9 is methylated on the arginine
residues in the arginine-rich motif, and that hRad9 inter-
acts with PRMT5, we reasoned that PRMT5 might
methylate hRad9. To test this hypothesis, an in vitro
methylation assay was performed using [
3H]-AdoMet
as a methyl donor. GST-hRad9 (arrow indicated) was
clearly methylated by FL-PRMT5 immunoprecipitated
from HEK 293T cells overexpressing FL-PRMT5 (lane 2
in Figure 2C). As a positive control, core histones were
also methylated by FL-PRMT5 (22) (lane 1 in Figure 2C).
Figure 1. hRad9 associates with PRMT5. (A) Silver-staining of proteins associated with hRad9. HEK 293T cells stably expressing FL-hRad9 were
immunoprecipitated with anti-FLAG antibody. Samples were resolved by SDS–PAGE and visualized by silver-staining (lane 2), lane 1 is a negative
control. The bands of interest were cut out and analyzed by a mass spectrometer. (B) Co-immunoprecipitation of FL-PRMT5 and HA-hRad9.
pcDNA3-6HA-hRad9 was transfected into HEK 293T cells along with pFLAG-CMV2-PRMT5 (lanes 1 and 4), pFLAG-CMV2-GFP (lanes 2 and 5:
negative control) and pFLAG-CMV2-hRad1 (lanes 3 and 6: positive control). The lysates were immunoprecipitated with anti-FLAG antibody, and
blotting membrane was probed with antibodies against HA (upper) and against FLAG (lower). In the cell lysates over-expressing hRad9 labeled with
antibody against tags (FLAG or HA), hRad9 appears as multiple protein bands, which are phosphoforms of hRad9; while the endogenous hRad9
appears only one band. In this ﬁgure and next ﬁgures, the over-expressed hRad9 (multiple bands) was marked with ‘}’. (C) Co-immunoprecipitation
of endogenous hRad9 and PRMT5. In the upper panel, endogenous PRMT5 was immunoprecipitated with anti-hRad9 polyclonal antibodies from
HeLa cell lysate (lane 2), but not with pre-immune antiserum (lane 3). (D) Co-immunoprecipitation of endogenous hRad9 and PRMT5, immunopre-
cipitated with anti-PRMT5 polyclonal antibody.
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motif were indeed the target for methylation by
PRMT5, we used a GST-hRad9 mutant (GST-hRad9-
3RA) as a substrate in which all Arg-172,174,175 were
mutated to Ala. As expected, this mutation resulted in
the complete loss of the methylation of the fusion
protein by FL-PRMT5 (lane 3 in Figure 2C). Taken
together, our results demonstrate that hRad9 is
arginine-methylated within the arginine-rich consensus
sequence by PRMT5.
Each of the three arginine residues in the arginine-rich
stretch is a potential target of methyltransferase enzymes.
To evaluate the arginine residues responsible for hRad9
methylation, we generated a series of mutants within the
arginine-rich stretch by substituting the corresponding
arginines with alanine. The mutated hRad9s were cloned
into the pcDNA3-6HA plasmid and tested for their ability
to serve as methyltransferase substrates in the in vivo assay
system. None of the single arginine mutations or
double-arginine mutations combinations signiﬁ-
cantly reduced hRad9 methylation, while the mutation
of all three arginines abolished methylation of hRad9
(Figure 2D and E). We conclude that the three arginine
residues (Arg172, Arg174 and Arg175) within the
arginine-rich region of hRad9 are all methylated in vivo.
We have found that hRad9 is methylated in vivo and can
be methylated by PRMT5 in vitro. To determine whether
PRMT5 is the physiological enzyme methylating hRad9,
we knocked down PRMT5 in HCT116 cells. Transfection
of PRMT5 ShRNA reduced its protein level by  80%
(Figure 3A), and this lower level of PRMT5 correlated
with a dramatic reduction in the hRad9 methylation
level (Figure 3B), suggesting that PRMT5 is the main
enzyme for hRad9 methylation in cells.
As hRad9 is critical for DNA damage repair and cell
cycle control, we want to know whether DNA damage
affects hRad9 methylation. To test this, HeLa cells were
mock- or HU-treated for 24h, then the cells were lysed
and immunoprecipitated with ab412, and probed with
anti-hRad9 monoclonal antibody. In HeLa cells, endogen-
ously methylated hRad9 was increased after cells were
treated with HU (Figure 3C), indicating that methylation
of hRad9 is DNA damage dependent.
Methylation of hRad9 regulates cellular sensitivity to
DNA damage
It has been reported that phosphorylation of hRad9 at
multiple amino acid residues inﬂuences cell sensitivity to
the replication inhibitor HU, and S/M and G2/M check-
point controls following genotoxin treatment (23–25).
Since hRad9 is methylated on its arginine-rich motif,
and methylation of hRad9 is DNA damage-dependent,
we asked whether the arginine-rich domain is important
for the known functions of hRad9 in DNA damage. We
therefore established mRad9
 /  ES cell clones stably ex-
pressing wild-type hRad9 and hRad9-3RA at levels
equivalent to the endogenous mRad9 level in mRad9
+/+
cells (Supplementary Figure S2). First, we tested the inﬂu-
ence of hRad9 methylation on cell survival against HU
and g rays. The mRad9
 /  ES cells expressing
hRad9-3RA were signiﬁcantly more sensitive to HU
than mRad9
+/+ cells and the mRad9
 /  ES cells ectopically
expressing hRad9. The hRad9-3RA-expressing mRad9
 / 
ES cells were equally sensitive to HU as the mRad9
 /  ES
cells at a low dose (100mM), and were slightly more sen-
sitive than the mRad9
 /  ES cells at higher doses (250 and
500mM) (Figure 4A). In contrast, mRad9
 /  cells express-
ing hRad9-3RA exhibited equal sensitivity to g rays at low
doses ( 6Gy) and only moderately higher sensitivity to
8Gy compared to mRad9
+/+ and mRad9
 /  cells
Figure 2. hRad9 is methylated in vivo and in vitro by PRMT5. (A)
Potential arginine methylation sites of hRad9 protein. The arginine-rich
motifs in the hRad9 and mRad9 proteins are indicated in italic type
and stars. (B) hRad9 is arginine methylated in vivo. Plasmids of
pcDNA3-6HA harboring wild-type hRad9 (lanes 3 and 6),
hRad9-3RA (lanes 2 and 5) or empty vector (lanes 1 and 4) were
transfected into HEK 293T cells. Ten percent of the lysate was used
for the control (left) and the remaining 90% (right) was immunopre-
cipitated with anti-mono/dimethylarginine antibodies (ab412), the
methylated hRad9 band is indicated by arrow. (C) hRad9 is methylated
by PRMT5 in vitro. The protein of FL-PRMT5 that was immunopre-
cipitated from HEK 293T cells overexpressing FL-PRMT5 was
incubated with commercial core histones (lane 1), recombinant
GST-hRad9 (lane 2) or GST-hRad9-3RA (lane 3) in the presence of
[
3H]-AdoMet as the methyl donor. Proteins were visualized by
Coomassie staining (upper) and
3H-labeled proteins were visualized
by ﬂuorography (lower), the GST-hRad9 and GST-hRad9-3RA
protein bands are indicated by arrows. (D) Single mutations of the
three arginines to alanines in the arginine-rich motif of hRad9 inﬂuence
the hRad9 methylation only slightly. The Arg172, Arg174 and Arg175
residues were mutated into alanine separately. Each mutated hRad9
was cloned into pcDNA3-6HA plasmid and transfected into HEK
293T cells. Cell lysates were immunoprecipitated with anti-mono/
dimethylarginine antibodies (ab412) and analyzed by western blotting
with anti-HA antibody. The methylated proteins are indicated by
arrows. (E) Double mutations of Arg172, Arg174 and Arg175 to
alanines do not eliminate the methylation of hRad9. The procedure
was the same as that in Figure 2D.
4722 Nucleic Acids Research, 2011,Vol.39, No. 11expressing wild-type hRad9 (Figure 4B). Collectively, our
results indicate that hRad9 methylation plays important
roles in the cellular response to HU, but a minor role in
cellular resistance to ionizing radiation. Next, we per-
formed a colony-formation assay to determine the effect
of PRMT5 knock-down on cellular sensitivity to HU.
HCT116 cells in which PRMT5 is knocked down are
more sensitive than cells expressing control ShRNA
(Figure 4C), suggesting that PRMT5 methylation of the
three arginines in hRad9 is required for cellular resistance
to DNA damage.
Loss of hRad9 methylation leads to S/M and G2/M
checkpoint defects
It has been reported that hRad9 is critical in S/M and G2/
M checkpoint controls (7,25). Here, we tested whether
hRad9 methylation plays roles in these checkpoints. The
classical cell cycle checkpoint analysis was introduced to
test S/M and G2/M checkpoint controls (7,13). To test the
G2/M cell cycle checkpoint, four types of cells (wild-type,
mRad9
 / , mRad9
 /  cells expressing wild-type hRad9
and mRad9
 /  cells expressing hRad9-3RA) were mock
irradiated or exposed to 6Gy of g rays. At various
post-irradiation times, the cells were ﬁxed and examined
with ﬂow cytometry. Another set of cells was treated with
colcemid immediately after radiation exposure and har-
vested 12h after irradiation. As shown in Figure 5A and
B, at 8h and 12h after exposure to 6-Gy g rays, more cells
expressing hRad9-3RA accumulated in the G1 and S
phase (arrow) than cells expressing wild-type hRad9,
and difference between the two types of cells above in
G1 phase is statistically signiﬁcant (Figure 5B).
mRad9
 /  and mRad9
+/+ cells were used as negative and
positive controls, respectively. A similar G2/M checkpoint
deﬁcient result of mRad9 knockout was reported previous-
ly by Hopkins et al. (7,26). As all the cells treated with
colcemid were blocked in G2/M at 12h after radiation
exposure, these results suggest that unmethylatable
hRad9-3RA leads to G2/M checkpoint deﬁciency.
To test the effect of the Rad9 methylation on S/M
checkpoint, the four types of cells used above were
mock-treated or treated with 1mM HU for 8h to
monitor S/M cell cycle checkpoint status. HU treatment
activated S/M checkpoint and arrested mRad9
+/+ cells in
the S phase, while cells with the Rad9 deletion exhibited
S/M checkpoint deﬁciency and were not blocked in the S
phase (4.99% cells entered the M phase without
completing DNA replication). S/M checkpoint deﬁciency
was also observed in mRad9
 /  cells expressing
hRad9-3RA; a higher percentage of cells (0.78%) express-
ing the mutant hRad9 entered the M phase without DNA
replication than was the case for normal cells (0.26%)
(Figure 5C). A statistical analysis shows that the differ-
ence is signiﬁcant (Figure 5D), demonstrating that methy-
lation of hRad9 plays an important role in S/M
checkpoint control. The effect of mutation of the three
arginine residues on the S/M checkpoint, although
Figure 3. Knock down of PRMT5 inﬂuences the arginine methylation of hRad9. (A) PRMT5 is knocked down in HCT 116 cells transiently
expressing PRMT5 ShRNA. Levels of PRMT5 and GAPDH were assayed in HCT116 cells expressing PRMT5 ShRNA or control ShRNA. (B)
Knockdown of PRMT5 reduces the arginine methylation of hRad9. HCT116 cells expressing PRMT5 ShRNA or control ShRNA were transfected
with pFLAG-CMV2-hRad9 and arginine methylation of hRad9 was detected in these cells. HCT116 cells expressing FL-hRad9-3RA were used as a
negative control. (C) Methylation of hRad9 is DNA damage dependent. HeLa cells were mock treated or treated with 0.5mM or 1mM HU for 24h.
Ten percent cells were lysed as input, the rest cells were lysed and immunoprecipitated with ab412 antibody and then immunoblotted with
anti-hRad9 monoclonal antibody.
Nucleic Acids Research, 2011,Vol.39, No. 11 4723statistically signiﬁcant (Figure 5C and D), is much weaker
than that on G2/M checkpoint (Figure 5A and B), sug-
gesting that the mechanisms by which Rad9 regulates the
two checkpoints might be different.
hRad9 methylation is required for genotoxin-induced Chk1
activation
It has been reported that both replication inhibitors and
g-rays irradiation trigger ATR-dependent Chk1 phos-
phorylation on Ser-345, which is essential for Chk1 acti-
vation (27,28), and that hRad9 phosphorylation is
required for Chk1 activation (25). In order to test
whether hRad9 methylation also plays a role in Chk1 ac-
tivation, we treated mRad9
+/+, mRad9
 / , mRad9
 /  ex-
pressing wild-type hRad9, and mRad9
 /  expressing
hRad9-3RA with 1mM HU for 12h or 10Gy of g rays.
Both treatments resulted in Chk1 Ser-345 phosphorylation
in mRad9
+/+ cells and mRad9
 /  cells which express
wild-type hRad9. However, the phosphorylation induced
was eliminated in mRad9
 /  cells and dramatically
reduced in mRad9
 /  cells expressing hRad9-3RA
(Figure 6A and B), indicating that hRad9 methylation
on the arginine-rich motif is required for downstream sig-
naling from hRad9 to Chk1 in response to genotoxic
stresses. Our results on IR sensitivity (Figure 4B) and
Chk1 phosphorylation (Figure 6A and B) indicate that
Chk1 activation (a strong effect) by Rad9 is largely unre-
lated to IR sensitivity (a weak effect), consistent with a
previous report (25).
Mutation of Arg-172,174,175 on hRad9 to Lys (hRad9-
3RK) shows the similar phenotype as to Ala
As arginine carries positive charge and the charge of Arg
175 is completely conserved (Arg or Lys) across the species
from tunicates to humans, suggesting the importance of
this arginine on hRad9 function. To avoid changing the
positive charge in the study of the methylation role on
hRad9 function, we mutated the three Args to Lys and
introduced the mutated hRad9 (hRad9-3RK) into
mRad9
 /  cells to study the known function of hRad9
in DNA damage resistance and cell cycle checkpoint acti-
vation. As seen in Supplementary Figure S4, the pheno-
types (cell cycle checkpoint control, cell sensitivity to
DNA damage and Chk1 activation) are similar to those
of hRad9-3RA. Therefore, we conclude that methylation,
but not the charge, is important for Chk1 activation and
resistance to DNA damage.
DISCUSSION
In this study we have documented that Rad9 is methylated
on arginines of its RGRR amino acid sequence stretch by
PRMT5 (Figure 2), and the methylation is critical for
cellular resistance to HU (Figure 4A), and for S/M and
G2/M (Figure 5) cell cycle checkpoint activation.
Human hRad9 is highly phosphorylated constitutively
and inductively (29). Both Tyr28 and Ser387 are required
for checkpoint activation (26). Tyr28 phosphorylation is
carried out by c-Abl tyrosine kinase in response to DNA
damage, and required for the interaction between hRad9
and Bcl-2 (30). hRad9 Ser272 was reported to be
phosphorylated by ATM and it was shown that the
overexpression of hRad9 (Ser272Ala) sensitized cells to g
rays slightly. However, a more detailed characterization
later did not conﬁrm the sensitization by the mutation.
The Ser328 of hRad9 can be phosphorylated by
Tousled-like kinase TLKB and the Ser328Ala mutation
leads to slight but statistically signiﬁcant enhancement of
sensitivity to g rays (31). hRad9 being involved in S/M and
G2/M checkpoint controls, and three different forms of
DNA repair (homologous recombination, base excision
and mismatch repairs) as well as apoptosis (1,13,32,33),
it is conceivable that the various functions of hRad9 are
regulated through phosphorylation on multiple sites by
multiple kinases. It is also not surprising that its activities
Figure 4. Methylation of hRad9 plays an important role in cell sensi-
tivity to HU, but a minor role in the sensitivity to g rays. (A) Sensitivity
of four types of cells (mRad9
+/+ ES cells, mRad9
 /  ES cells and the
two mRad9
 /  ES cells that stably express hRad9 WT and
hRad9-3RA, respectively) to HU. The cells were treated with various
concentrations of HU or mock-treated for 24h. After washing with
PBS and addition of fresh medium, cells were allowed to grow for 2
weeks to form colonies. (B) Sensitivity of the four types of cells to g
rays. The cells were exposed to various doses of g rays and were
allowed to grow for 2 weeks to form colonies. (C) PRMT5 knockdown
inﬂuences cell sensitivity to HU. Cell sensitivity of HCT116 cells ex-
pressing PRMT5 ShRNA or control ShRNA to various doses of HU
were measured as in Figure 3A.
4724 Nucleic Acids Research, 2011,Vol.39, No. 11are modulated by other post-translational modiﬁcations
such as methylation shown in this study.
Cellular sensitivity to HU is most severely affected by
mutating the three arginines in RGRR methylation site
into alanines (Figure 4A), but only moderately changed
cellular sensitivity to g rays at high dose (Figure 4B).
Similar phenotypes were also observed when all the
eight phosphorylation sites of the hRad9 C-terminus are
altered (25). The hRad9 C-terminus stretches out of the
ring formed by Rad9, Rad1 and Hus1. The RGRR methy-
lation site (amino acids 172–175) is located on the ring.
The hRad9 Tyr28 is also situated on the 9-1-1 ring
(Figure 6D) and critical for HU induced S/M checkpoint
activation. That the three separate sites are all needed in
response to HU treatment suggests that different portions
of hRad9 coordinate the events critical for managing the
disturbance caused by HU. In contrast to the response to
HU treatment, the mutations on the C-terminus and
RGRR cause very slight changes in cellular resistance to
g rays suggest that the mechanism of the response to g
rays irradiation is not overlapped with those of the
response to HU treatment. The g rays cause DNA
double-strand breaks, and two studies demonstrated that
Rad9 and its partner Hus1 in the 9-1-1 complex repaired
double-strand breaks by homologous recombination
(4,34). Further study will be needed to map the region(s)
of the Rad9 protein that is responsible for the recombin-
ation repair function.
To understand the functional mechanism of Rad9
methylation in cell cycle checkpoint activation and DNA
damage response, we have investigated the roles of Rad9
methylation in the formation of the 9-1-1 complex, DNA
damage induced Rad9 association onto chromatin, but
Rad9 with mutations on all the three arginines in the
RGRR sequence showed no effect on the 9-1-1 complex
formation (Supplementary Figure S1) and DNA damage
induced Rad9 association onto chromatin (Supplementary
Figure S3). It is worth noting that we used overexpressed,
instead of endogenous, Rad1 and Hus1 to test the effect of
the arginines methylation on the 9-1-1 complex formation
Figure 5. Deﬁciency of hRad9 methylation leads to S/M and G2/M checkpoint control defects. (A) The lack of hRad9 methylation affects ionizing
radiation-induced G2 arrest. The four types of mouse ES cells (mRad9
+/+, mRad9
 / , mRad9
 /  cells expressing wild-type hRad9 and mRad9
 /  cells
expressing hRad9-3RA, respectively) were mock-treated or irradiated with 6Gy of g rays in the absence or presence of colcemid. Regions of the
proﬁles corresponding to G1, S or G2/M are delineated above the ﬁrst row of graphs, and the ratio of cells in G1, S or G2/M phase were shown.
(B) Statistics analysis of the relative cell number in G1 phase out of three independent experiments in (A). Double asterisks indicate extremely
signiﬁcant difference (P < 0.01) and asterisk indicates signiﬁcant (P<0.05). (C) Lack of hRad9-methylation results in the S/M checkpoint control
defect. The four types of cells were treated or mock-treated with 1mM HU for 8h. Cells were collected and labeled with the mitotic marker
phosphor-histone H3 antibody, stained with propidium iodide, and analyzed by ﬂow cytometry. Staining intensity for PI (x-axis) is plotted versus
that for phosphor-histone H3 (y-axis). The cells in the boxed region are premature mitotic cells. Numbers above the box are the percentage of the
cells boxed in the total cells. (D) Statistics analysis of relative premature mitotic cells derived from three independent experiments descried in (C).
In (B) and (D), Double asterisks indicate extremely signiﬁcant difference (P<0.01) and asterisk indicates signiﬁcance (P<0.05).
Nucleic Acids Research, 2011,Vol.39, No. 11 4725because proper anti-Rad1 and anti-Hus1 are not avail-
able, thus small effect of the Rad9 methethylation on
the 9-1-1 complex formation is still possible.
We noticed that knocking down PRMT5 did sensitize
HCT116 to HU but the sensitized extent was less than the
mutations of the arginines on Rad9 using mouse ES cells
(Figure 4A and C). We also found that knocking down
PRMT5 did not impair S/M checkpoint activation in
HCT116 cells (data not shown). These differences may
reﬂect the differences of these two cell types. Indeed,
untreated HCT116 cells were much more resistant to
HU than wild-type mouse ES cells (Figure 4A and C).
A large body of evidence demonstrates that the phos-
phorylation/dephosphorylation of proteins functioning in
cell cycle checkpoint controls and DNA damage repair
plays an essential role in orchestrating molecular events
required for maintaining genome integrity (35,36).
Arginine methylation of histones has been demonstrated
to be critical in the regulation of transcription induction/
repression and chromatin remodeling, and arginine
methylation of other cellular proteins is also emerging to
play important roles in other cellular events including
DNA damage repair and cell cycle checkpoint controls
(10,37). DNA polymerase b methylation by PRMT6
strongly stimulates the activity of this enzyme and is
required for efﬁcient DNA base excision repair (22).
MRE11 methylation by PRMT1 and p53 methylation
by PRMT5 play important roles in G1/S and intra-S
phase checkpoint controls, respectively (18,38). In this
study we have documented that Rad9 is methylated on
the arginines in its RGRR amino acid sequence stretch
by PRMT5, and that this methylation is critical for
cellular resistance to DNA damage caused by HU, and
for S/M and G2/M cell cycle checkpoints activation.
Therefore, protein arginine methylation is important for
the activation of at least four of the ﬁve major cell cycle
checkpoints; the role of arginine methylation in spindle
checkpoint control remains to be tested. Although the
DNA repairs behind the hRad9 methylation-conferred
cellular resistance to HU treatment have not been
identiﬁed, hRad9 has been shown to play important
roles in DNA base excision, mismatch and homologous
recombination repairs, and these repairs have been shown
to be at least partially responsible for resistance to HU
treatment (1,39). In summary (Figure 6C), in addition to
protein phosphorylation, protein arginine methylation has
emerged as another major factor critical for cell cycle
checkpoint controls and DNA damage repairs, and thus
for maintaining genome integrity.
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